46
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis

, , , , , , & show all
Pages 1793-1801 | Published online: 23 Mar 2017

Figures & data

Figure 1 Flow diagram of the study selection process.

Abbreviations: NQO1, NAD(P)H:quinone oxidoreductase; AL, acute leukemia; AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia.
Figure 1 Flow diagram of the study selection process.

Table 1 Characteristics of included studies

Figure 2 The associations between NQO1 C609T and the ALL risk. (A) Calculated ORs and 95% CIs for the association. (B) Sensitivity analysis via deletion of each individual study. (C) Cumulative meta-analysis according to publication year. (D) Trim-and-fill plot to correct publication bias.

Note: Weights are from random-effects analysis.
Abbreviations: NQO1, NAD(P)H:quinone oxidoreductase; ALL, acute lymphoblastic leukemia; OR, odds ratio; CI, confidence interval.
Figure 2 The associations between NQO1 C609T and the ALL risk. (A) Calculated ORs and 95% CIs for the association. (B) Sensitivity analysis via deletion of each individual study. (C) Cumulative meta-analysis according to publication year. (D) Trim-and-fill plot to correct publication bias.

Table 2 Subgroup analysis for the association of NQO1 C609T with AL risk

Figure 3 The associations between NQO1 C609T and AML risk. (A) Calculated ORs and 95% CIs for the association. (B) Funnel plot for detecting publication bias.

Note: Weights are from random-effects analysis.
Abbreviations: NQO1, NAD(P)H:quinone oxidoreductase; AML, acute myeloid leukemia; OR, odds ratio; CI, confidence interval.
Figure 3 The associations between NQO1 C609T and AML risk. (A) Calculated ORs and 95% CIs for the association. (B) Funnel plot for detecting publication bias.